|
|
Post by lakers on Oct 3, 2016 14:19:07 GMT -5
1. Mnkd gonna conduct EpiHale clinical trial for the next 3-4 mos. After that, Mnkd will review the result w/ FDA early 1Q17.
The whole process to FDA approval is ~ 10 mos.
2. Mnkd will co-market Afrezza in NFL game-day pamphlets for SD Chargers, LA Rams, Phily Eagles, Chicago Bears. These are large markets. An Ads could show up in USA Today.
3. Mnkd has been negotiating a settlement w/ Sanofi. Matt has traveled in the last 2 weeks. Mnkd will announce when there is some news.
4. BoD has plan to address delisting, extend the runway.
5. Of course Afrezza ramp-up would help pps. Afrezza story was printed in trade journals.
I can't disclose my source. I recite to the best of my recollection.
|
|
|
|
Post by rockstarrick on Oct 3, 2016 14:28:01 GMT -5
1. Mnkd gonna conduct EpiHale clinical trial for the next 3-4 mos. After that, Mnkd will review the result w/ FDA early 1Q17. The whole process to FDA approval is ~ 10 mos. 2. Mnkd will co-market Afrezza in NFL game-day pamphlets for SD Chargers, LA Rams, Phily Eagles, Chicago Bears. These are large markets. An Ads could show up in USA Today. 3. Mnkd has been negotiating a settlement w/ Sanofi. Matt has traveled in the last 2 weeks. Mnkd will announce when there is some news. 4. BoD has plan to address delisting, extend the runway. 5. Of course Afrezza ramp-up would help pps. Afrezza story was printed in trade journals. I can't disclose my source. I recite to the best of my recollection. Thanks Lakers |
|
|
|
Post by dg1111 on Oct 3, 2016 14:32:36 GMT -5
Is the ~10 months timeline to FDA approval for Epihale from today or 1Q17?
Any idea when some of this info may become public? Q3 conference call?
|
|
|
|
Post by lakers on Oct 3, 2016 14:36:50 GMT -5
Is the ~10 months timeline to FDA approval for Epihale from today or 1Q17? Any idea when some of this info may become public? Q3 conference call? ~10 mos from early 1Q17. SH should have a need to know given delisting notice. |
|
|
|
Post by madog365 on Oct 3, 2016 14:43:24 GMT -5
1. Mnkd gonna conduct EpiHale clinical trial for the next 3-4 mos. After that, Mnkd will review the result w/ FDA early 1Q17. The whole process to FDA approval is ~ 10 mos. 2. Mnkd will co-market Afrezza in NFL game-day pamphlets for SD Chargers, LA Rams, Phily Eagles, Chicago Bears. These are large markets. An Ads could show up in USA Today. 3. Mnkd has been negotiating a settlement w/ Sanofi. Matt has traveled in the last 2 weeks. Mnkd will announce when there is some news. 4. BoD has plan to address delisting, extend the runway. 5. Of course Afrezza ramp-up would help pps. Afrezza story was printed in trade journals. I can't disclose my source. I recite to the best of my recollection. #2 - i have only head about MLB game day pamphlets during playoff time. Are you sure that is not what you mean here? |
|
|
|
Post by kbrion77 on Oct 3, 2016 14:45:23 GMT -5
1. Mnkd gonna conduct EpiHale clinical trial for the next 3-4 mos. After that, Mnkd will review the result w/ FDA early 1Q17. The whole process to FDA approval is ~ 10 mos. 2. Mnkd will co-market Afrezza in NFL game-day pamphlets for SD Chargers, LA Rams, Phily Eagles, Chicago Bears. These are large markets. An Ads could show up in USA Today. 3. Mnkd has been negotiating a settlement w/ Sanofi. Matt has traveled in the last 2 weeks. Mnkd will announce when there is some news. 4. BoD has plan to address delisting, extend the runway. 5. Of course Afrezza ramp-up would help pps. Afrezza story was printed in trade journals. I can't disclose my source. I recite to the best of my recollection. Between you and Kevinmik you have literally been incorrect on almost every call you have made with MNKD. From SNY buying shares, full SNY buyout, Afrezza worldwide expansion, MNKD partnering with TEVA, MNKD partnering with GSK, huge SNY settlement, and the list goes on. It's posts like this that are the most dangerous to new investors trying to get an understanding with the company. I've grown to only reading what is in the SEC filings along with a press release issued by the company when something material happens, I suggest everyone else do the same. |
|
|
|
Post by gamblerjag on Oct 3, 2016 14:58:07 GMT -5
actually the Charger games are probably the biggest market.. since most fans are from visiting teams locations. So your getting two locations in one!!  |
|
|
|
Post by slugworth008 on Oct 3, 2016 15:01:34 GMT -5
actually the Charger games are probably the biggest market.. since most fans are from visiting teams locations. So your getting two locations in one!! Sounds like Atlanta Falcons games as well. |
|
|
|
Post by prvs on Oct 3, 2016 15:04:49 GMT -5
1. Mnkd gonna conduct EpiHale clinical trial for the next 3-4 mos. After that, Mnkd will review the result w/ FDA early 1Q17. The whole process to FDA approval is ~ 10 mos. 2. Mnkd will co-market Afrezza in NFL game-day pamphlets for SD Chargers, LA Rams, Phily Eagles, Chicago Bears. These are large markets. An Ads could show up in USA Today. 3. Mnkd has been negotiating a settlement w/ Sanofi. Matt has traveled in the last 2 weeks. Mnkd will announce when there is some news. 4. BoD has plan to address delisting, extend the runway. 5. Of course Afrezza ramp-up would help pps. Afrezza story was printed in trade journals. I can't disclose my source. I recite to the best of my recollection. This is a case of throw it against the wall and see what sticks. Unfortunately somebody greased the wall and it all slid off. Go figure. |
|
|
|
Post by gamblerjag on Oct 3, 2016 15:06:46 GMT -5
Hey Slug.. no idea that ATL had fair weathered fans. ... I'm sure the falcons will kick Chargers butt in a few weeks.
|
|
|
|
Post by lakers on Oct 3, 2016 15:27:41 GMT -5
1. Mnkd gonna conduct EpiHale clinical trial for the next 3-4 mos. After that, Mnkd will review the result w/ FDA early 1Q17. The whole process to FDA approval is ~ 10 mos. 2. Mnkd will co-market Afrezza in NFL game-day pamphlets for SD Chargers, LA Rams, Phily Eagles, Chicago Bears. These are large markets. An Ads could show up in USA Today. 3. Mnkd has been negotiating a settlement w/ Sanofi. Matt has traveled in the last 2 weeks. Mnkd will announce when there is some news. 4. BoD has plan to address delisting, extend the runway. 5. Of course Afrezza ramp-up would help pps. Afrezza story was printed in trade journals. I can't disclose my source. I recite to the best of my recollection. #2 - i have only head about MLB game day pamphlets during playoff time. Are you sure that is not what you mean here? NFL game day pamphlet is a surprise in addition to MLB playoffs. It makes sense as NFL is the largest market in U.S. Mgmt must be confident about the funding. These Mktgs are not cheap. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Oct 3, 2016 15:31:58 GMT -5
1. Mnkd gonna conduct EpiHale clinical trial for the next 3-4 mos. After that, Mnkd will review the result w/ FDA early 1Q17. The whole process to FDA approval is ~ 10 mos. 2. Mnkd will co-market Afrezza in NFL game-day pamphlets for SD Chargers, LA Rams, Phily Eagles, Chicago Bears. These are large markets. An Ads could show up in USA Today. 3. Mnkd has been negotiating a settlement w/ Sanofi. Matt has traveled in the last 2 weeks. Mnkd will announce when there is some news. 4. BoD has plan to address delisting, extend the runway. 5. Of course Afrezza ramp-up would help pps. Afrezza story was printed in trade journals. I can't disclose my source. I recite to the best of my recollection. Between you and Kevinmik you have literally been incorrect on almost every call you have made with MNKD. From SNY buying shares, full SNY buyout, Afrezza worldwide expansion, MNKD partnering with TEVA, MNKD partnering with GSK, huge SNY settlement, and the list goes on. It's posts like this that are the most dangerous to new investors trying to get an understanding with the company. I've grown to only reading what is in the SEC filings along with a press release issued by the company when something material happens, I suggest everyone else do the same. I always thought they were the same person. If someone form a message board could get their hands on such information then so could every billion $ hedge fund thus we would see better volume. |
|
|
|
Post by cjm18 on Oct 3, 2016 15:32:13 GMT -5
1. Mnkd gonna conduct EpiHale clinical trial for the next 3-4 mos. After that, Mnkd will review the result w/ FDA early 1Q17. The whole process to FDA approval is ~ 10 mos. 2. Mnkd will co-market Afrezza in NFL game-day pamphlets for SD Chargers, LA Rams, Phily Eagles, Chicago Bears. These are large markets. An Ads could show up in USA Today. 3. Mnkd has been negotiating a settlement w/ Sanofi. Matt has traveled in the last 2 weeks. Mnkd will announce when there is some news. 4. BoD has plan to address delisting, extend the runway. 5. Of course Afrezza ramp-up would help pps. Afrezza story was printed in trade journals. I can't disclose my source. I recite to the best of my recollection. Between you and Kevinmik you have literally been incorrect on almost every call you have made with MNKD. From SNY buying shares, full SNY buyout, Afrezza worldwide expansion, MNKD partnering with TEVA, MNKD partnering with GSK, huge SNY settlement, and the list goes on. It's posts like this that are the most dangerous to new investors trying to get an understanding with the company. I've grown to only reading what is in the SEC filings along with a press release issued by the company when something material happens, I suggest everyone else do the same. But did he have sources before? Or just wishful thinking? |
|
|
|
Post by madog365 on Oct 3, 2016 15:37:14 GMT -5
#2 - i have only head about MLB game day pamphlets during playoff time. Are you sure that is not what you mean here? NFL game day pamphlet is a surprise in addition to MLB playoffs. It makes sense as NFL is the largest market in U.S. Mgmt must be confident about the funding. These Mktgs are not cheap. Anything more you can provide on the "comarketing" front? Will it be with JDRF? I know they get some free marketing exposure. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Oct 3, 2016 15:37:52 GMT -5
Between you and Kevinmik you have literally been incorrect on almost every call you have made with MNKD. From SNY buying shares, full SNY buyout, Afrezza worldwide expansion, MNKD partnering with TEVA, MNKD partnering with GSK, huge SNY settlement, and the list goes on. It's posts like this that are the most dangerous to new investors trying to get an understanding with the company. I've grown to only reading what is in the SEC filings along with a press release issued by the company when something material happens, I suggest everyone else do the same. I always thought they were the same person. If someone form a message board could get their hands on such information then so could every billion $ hedge fund thus we would see better volume. agreed. with almost 100 million short interest, they would be the first to get a whiff of positive development. For a little bit of history , many people ( every one knows who they are ) were saying SNY would drop afrezza the first chance back from Jan/feb of 2015 |
|
